DMPI - DelMar Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 514.23M
Enterprise Value 314.97M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)11.76
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.34

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-93.21%
Return on Equity (ttm)-185.43%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.15M
Net Income Avi to Common (ttm)-11.31M
Diluted EPS (ttm)-0.62
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.97M
Total Cash Per Share (mrq)0.27
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.30
Book Value Per Share (mrq)0.05

Cash Flow Statement

Operating Cash Flow (ttm)-9.85M
Levered Free Cash Flow (ttm)-5.68M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.09
52-Week Change 3-31.04%
S&P500 52-Week Change 37.55%
52 Week High 31.82
52 Week Low 30.33
50-Day Moving Average 30.67
200-Day Moving Average 30.76

Share Statistics

Avg Vol (3 month) 3114.34k
Avg Vol (10 day) 359.8k
Shares Outstanding 522.41M
Float 18.98M
% Held by Insiders 17.65%
% Held by Institutions 113.99%
Shares Short (Sep 28, 2018) 41.23M
Short Ratio (Sep 28, 2018) 48.99
Short % of Float (Sep 28, 2018) 45.84%
Short % of Shares Outstanding (Sep 28, 2018) 45.47%
Shares Short (prior month Aug 31, 2018) 41.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A